THE SHARE: Change: -0.01 SEK (-4.53%) / Price: 0.13 SEK / Feb 11, 2026, 5:29 pm (CET)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Spago Nanomedical in media

  • 14 Apr, 2014
    Ionising radiation-free whole-body MRI in children and young adults with cancer
  • 7 Apr, 2014
    Spago Imaging enters a new phase
  • 26 Mar, 2014
    Spago Imaging AB presents data on new MR contrast agent Spago Pix at ECR in Vienna.
  • 26 Sep, 2013
    Spago verifies nanoparticle properties at Maxlab.
  • 3 Jun, 2013
    Information on initial cost of SPAGO shares for shareholders of Accelerator
  • 13 May, 2013
    Breast MRI helps assess patient prognosis and change treatment plan
  • 16 Apr, 2013
    SPAGO Pix Properties Verified at MAX-Lab
  • 27 Dec, 2012
    The SPAGO BTAs are traded on AktieTorget
  • 11 Dec, 2012
    SPAGO’s issue of shares fully subscribed
  • 27 Nov, 2012
    Veckans Affärer: ” Håll koll på spännande avknoppning”
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Previous
  • Next
Back
  • Spago Nanomedical in media
  • Press Releases
  • Subscribe
  • Presentations
  • Events
  • Image Bank

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications